In this issue:
First-in-human trial of precem-TcT in metastatic CRC
Tumour-agnostic genomically-matched therapy promising for solid tumours
Postoperative ctDNA or CTC positivity portends recurrence in patients with CRLM
PICC: neoadjuvant PD-1 blockade promising for dMMR/MSI-H CRC
Is follow-up imaging of any value in resected cutaneous melanoma?
AlphaBet: 177Lu-PSMA-I&T plus 223Ra combo feasible for mCRPC
Lorazepam best for persistent agitated delirium at end of life
Total neoadjuvant therapy for locally advanced rectal cancer
Novel anticancer treatments at end-of-life risk excess health services use
TTV outperforms RECIST1.1 for prognosis in patients with CRLM
Please login below to download this issue (PDF)